These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6107136)

  • 1. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
    Manchanda R; Hirsch SR
    Br J Psychiatry; 1986 Jun; 148():701-7. PubMed ID: 2877702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
    Karniol IG; Portela W
    Braz J Med Biol Res; 1982 Dec; 15(6):389-94. PubMed ID: 6135468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.
    Kramer MS; Gorkin RA; DiJohnson C; Sheves P
    Biol Psychiatry; 1988 Nov; 24(7):823-7. PubMed ID: 2906547
    [No Abstract]   [Full Text] [Related]  

  • 8. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 9. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.
    Adler L; Angrist B; Peselow E; Corwin J; Maslansky R; Rotrosen J
    Br J Psychiatry; 1986 Jul; 149():42-5. PubMed ID: 2877708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol as a primary treatment of neuroleptic-induced akathisia.
    Irwin M; Sullivan G; Van Putten T
    Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
    Peet M; Bethell MS; Coates A; Khamnee AK; Hall P; Cooper SJ; King DJ; Yates RA
    Br J Psychiatry; 1981 Aug; 139():105-11. PubMed ID: 7030442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
    Kramer MS; Gorkin R; DiJohnson C
    Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M; Middlemiss DN; Yates RA
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextro-propranolol and depressive symptoms in a schizophrenic population.
    Manchanda R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):625-32. PubMed ID: 3321153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
    Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
    Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.